[go: up one dir, main page]

GB202304657D0 - Atovaquine compositions - Google Patents

Atovaquine compositions

Info

Publication number
GB202304657D0
GB202304657D0 GBGB2304657.6A GB202304657A GB202304657D0 GB 202304657 D0 GB202304657 D0 GB 202304657D0 GB 202304657 A GB202304657 A GB 202304657A GB 202304657 D0 GB202304657 D0 GB 202304657D0
Authority
GB
United Kingdom
Prior art keywords
atovaquine
compositions
atovaquine compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2304657.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Priority to GBGB2304657.6A priority Critical patent/GB202304657D0/en
Publication of GB202304657D0 publication Critical patent/GB202304657D0/en
Priority to PCT/GB2024/050860 priority patent/WO2024201057A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046—Solid microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053—Methods for producing microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
GBGB2304657.6A 2023-03-29 2023-03-29 Atovaquine compositions Ceased GB202304657D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2304657.6A GB202304657D0 (en) 2023-03-29 2023-03-29 Atovaquine compositions
PCT/GB2024/050860 WO2024201057A1 (en) 2023-03-29 2024-03-28 Atovaquone solid compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2304657.6A GB202304657D0 (en) 2023-03-29 2023-03-29 Atovaquine compositions

Publications (1)

Publication Number Publication Date
GB202304657D0 true GB202304657D0 (en) 2023-05-10

Family

ID=86228208

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2304657.6A Ceased GB202304657D0 (en) 2023-03-29 2023-03-29 Atovaquine compositions

Country Status (2)

Country Link
GB (1) GB202304657D0 (en)
WO (1) WO2024201057A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2399084B (en) 2002-07-30 2007-01-31 Univ Liverpool Porous beads and method of production thereof
GB0613925D0 (en) 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
US20100028425A1 (en) * 2008-07-31 2010-02-04 Glenmark Generics Ltd. Pharmaceutical composition of atovaquone
PL2547332T3 (en) * 2010-03-16 2019-07-31 Titan Pharmaceuticals, Inc. Heterogeneous implantable devices for drug delivery
CA3027817C (en) 2016-06-16 2023-12-19 The University Of Liverpool Chemical composition for the treatment and prophylaxis of systemic infections
CN110022794A (en) * 2016-10-05 2019-07-16 泰坦医药品公司 The implantable device for drug delivery of burst release with reduction

Also Published As

Publication number Publication date
WO2024201057A1 (en) 2024-10-03

Similar Documents

Publication Publication Date Title
IL315791A (en) Compositions
GB202013432D0 (en) Compositions
IL315415A (en) Compositions comprising aticaprant
GB202015836D0 (en) Compositions
GB202105461D0 (en) Compositions
GB202102704D0 (en) Compositions
GB202413620D0 (en) Aquafeed compositions
GB202403478D0 (en) Compositions
GB202319731D0 (en) Compositions
GB202319163D0 (en) Compositions
GB202315800D0 (en) Compositions
GB202314139D0 (en) Aquafeed compositions
IL317503A (en) Risankizumab compositions
GB202307781D0 (en) Compositions
GB202307786D0 (en) Compositions
GB202306859D0 (en) Compositions
IL315870A (en) Cannabinoid-containing compositions
GB202304657D0 (en) Atovaquine compositions
GB202304423D0 (en) Compositions
GB202303738D0 (en) Compositions
IL315676A (en) Cannabinoid-containing compositions
GB202302791D0 (en) Compositions
GB202219079D0 (en) Compositions
GB202216648D0 (en) Compositions
GB202209319D0 (en) RNA-LNP compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)